Navellier & Associates Inc Guardant Health, Inc. Transaction History
Navellier & Associates Inc
- $915 Million
- Q3 2025
A detailed history of Navellier & Associates Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Navellier & Associates Inc holds 7,754 shares of GH stock, worth $757,643. This represents 0.05% of its overall portfolio holdings.
Number of Shares
7,754Holding current value
$757,643% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding GH
# of Institutions
433Shares Held
124MCall Options Held
1.51MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA11.9MShares$1.16 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$1.1 Billion0.01% of portfolio
-
Baillie Gifford & CO5.13MShares$501 Million0.25% of portfolio
-
Invesco Ltd. Atlanta, GA4.93MShares$482 Million0.05% of portfolio
-
Capital International Investors Los Angeles, CA4.69MShares$458 Million0.05% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $9.99B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...